FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:FMS • US3580291066
22.98 USD
+0.38 (+1.68%)
At close: Feb 3, 2026
22.98 USD
0 (0%)
After Hours: 2/3/2026, 4:15:00 PM
FMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. FMS has only an average score on both its financial health and profitability. FMS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
- In the past year FMS was profitable.
- In the past year FMS had a positive cash flow from operations.
- In the past 5 years FMS has always been profitable.
- Each year in the past 5 years FMS had a positive operating cash flow.
1.2 Ratios
- FMS has a Return On Assets (2.33%) which is comparable to the rest of the industry.
- With a decent Return On Equity value of 5.55%, FMS is doing good in the industry, outperforming 60.78% of the companies in the same industry.
- FMS has a Return On Invested Capital of 3.95%. This is comparable to the rest of the industry: FMS outperforms 50.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for FMS is significantly below the industry average of 9.16%.
- The last Return On Invested Capital (3.95%) for FMS is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
- FMS has a Profit Margin of 3.66%. This is in the better half of the industry: FMS outperforms 73.53% of its industry peers.
- In the last couple of years the Profit Margin of FMS has declined.
- Looking at the Operating Margin, with a value of 7.19%, FMS is in the better half of the industry, outperforming 72.55% of the companies in the same industry.
- FMS's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 25.00%, FMS is in line with its industry, outperforming 51.96% of the companies in the same industry.
- In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FMS is destroying value.
- The number of shares outstanding for FMS remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, FMS has less shares outstanding
- FMS has a better debt/assets ratio than last year.
2.2 Solvency
- FMS has an Altman-Z score of 1.78. This is a bad value and indicates that FMS is not financially healthy and even has some risk of bankruptcy.
- FMS's Altman-Z score of 1.78 is in line compared to the rest of the industry. FMS outperforms 45.10% of its industry peers.
- FMS has a debt to FCF ratio of 5.97. This is a neutral value as FMS would need 5.97 years to pay back of all of its debts.
- The Debt to FCF ratio of FMS (5.97) is better than 62.75% of its industry peers.
- A Debt/Equity ratio of 0.73 indicates that FMS is somewhat dependend on debt financing.
- FMS has a Debt to Equity ratio of 0.73. This is comparable to the rest of the industry: FMS outperforms 50.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.78 |
ROIC/WACC0.78
WACC5.1%
2.3 Liquidity
- FMS has a Current Ratio of 1.36. This is a normal value and indicates that FMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.36, FMS is in line with its industry, outperforming 50.00% of the companies in the same industry.
- A Quick Ratio of 1.00 indicates that FMS may have some problems paying its short term obligations.
- With a Quick ratio value of 1.00, FMS is not doing good in the industry: 65.69% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 16.77% over the past year.
- Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
- Looking at the last year, FMS shows a small growth in Revenue. The Revenue has grown by 2.10% in the last year.
- Measured over the past years, FMS shows a small growth in Revenue. The Revenue has been growing by 2.04% on average per year.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
- FMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.37% yearly.
- The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 10.35, the valuation of FMS can be described as reasonable.
- FMS's Price/Earnings ratio is rather cheap when compared to the industry. FMS is cheaper than 90.20% of the companies in the same industry.
- FMS is valuated cheaply when we compare the Price/Earnings ratio to 28.41, which is the current average of the S&P500 Index.
- FMS is valuated reasonably with a Price/Forward Earnings ratio of 9.40.
- 91.18% of the companies in the same industry are more expensive than FMS, based on the Price/Forward Earnings ratio.
- FMS is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.35 | ||
| Fwd PE | 9.4 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, FMS is valued cheaply inside the industry as 88.24% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 93.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.49 | ||
| EV/EBITDA | 6.38 |
4.3 Compensation for Growth
- FMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as FMS's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.85%, FMS has a reasonable but not impressive dividend return.
- FMS's Dividend Yield is rather good when compared to the industry average which is at 0.47. FMS pays more dividend than 99.02% of the companies in the same industry.
- FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.85% |
5.2 History
- The dividend of FMS has a limited annual growth rate of 0.31%.
- FMS has been paying a dividend for at least 10 years, so it has a reliable track record.
- The dividend of FMS decreased in the last 3 years.
Dividend Growth(5Y)0.31%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- FMS pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
- FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
22.98
+0.38 (+1.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners43.91%
Inst Owner Change-0.31%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.49B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.86
Price Target27.89 (21.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.85% |
Yearly Dividend0.71
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)0.55%
PT rev (3m)-3.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.21%
EPS NY rev (1m)0%
EPS NY rev (3m)2.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.35 | ||
| Fwd PE | 9.4 | ||
| P/S | 0.58 | ||
| P/FCF | 6.49 | ||
| P/OCF | 4.54 | ||
| P/B | 0.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.38 |
EPS(TTM)2.22
EY9.66%
EPS(NY)2.44
Fwd EY10.64%
FCF(TTM)3.54
FCFY15.41%
OCF(TTM)5.07
OCFY22.05%
SpS39.63
BVpS26.13
TBVpS-3.81
PEG (NY)0.48
PEG (5Y)N/A
Graham Number36.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.78 |
F-Score5
WACC5.1%
ROIC/WACC0.78
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.33%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE-ADR / FMS FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?
ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
What is the profitability of FMS stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 21.73% in the next year.
Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?
The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 58.83%.